- Location
1
result for "
treatment of shingles
"-
Synergy Pharmaceuticals Has Signed an Asset Purchase Agreement
Dec 3, 2012Synergy Pharmaceuticals has signed an asset purchase agreement to acquire FV-100 shingles drug from Bristol-Myers Squibb Company. FV-100 is an orally available nucleoside analogue, at present being developed for the treatment of shingles, ...
Tags: Synergy Pharmaceuticals, treatment of shingles, FV-100
